Clinical Effectiveness of In-office Bleaching Activated With a LED/Laser Device
NCT ID: NCT01231243
Last Updated: 2011-12-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
60 participants
INTERVENTIONAL
2011-01-31
2011-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The hypothesis of this study is that the effectiveness of light activation tooth bleaching in dependent on the hydrogen peroxide concentration employed.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
35% hydrogen peroxide control
The tooth bleaching will be performed using a high hydrogen peroxide concentration (35%) without light-activation with LED/light device
in-office bleaching with/without light
Two clinical sessions of tooth bleaching will be performed in each patient with a 1-week interval between them. In each session, three 15-min applications of the gel will be done using one of the two concentrations under investigation. In half of the sample of each concentration, the gel will be activated with a LED/laser device for a total of 3 min, as specified by the DMC manufacturer.
20% hydrogen peroxide
The tooth bleaching will be performed with a low hydrogen peroxide concentration (20%) without light activation with a LED/laser device
in-office bleaching with/without light
Two clinical sessions of tooth bleaching will be performed in each patient with a 1-week interval between them. In each session, three 15-min applications of the gel will be done using one of the two concentrations under investigation. In half of the sample of each concentration, the gel will be activated with a LED/laser device for a total of 3 min, as specified by the DMC manufacturer.
35% hydrogen peroxide + light
The tooth bleaching will be performed with a high hydrogen peroxide concentration (35%) associated with LED/laser light activation
in-office bleaching with/without light
Two clinical sessions of tooth bleaching will be performed in each patient with a 1-week interval between them. In each session, three 15-min applications of the gel will be done using one of the two concentrations under investigation. In half of the sample of each concentration, the gel will be activated with a LED/laser device for a total of 3 min, as specified by the DMC manufacturer.
20% hydrogen peroxide + light
The tooth bleaching will be performed with a low hydrogen peroxide concentration (20%) associated with LED/laser light activation
in-office bleaching with/without light
Two clinical sessions of tooth bleaching will be performed in each patient with a 1-week interval between them. In each session, three 15-min applications of the gel will be done using one of the two concentrations under investigation. In half of the sample of each concentration, the gel will be activated with a LED/laser device for a total of 3 min, as specified by the DMC manufacturer.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
in-office bleaching with/without light
Two clinical sessions of tooth bleaching will be performed in each patient with a 1-week interval between them. In each session, three 15-min applications of the gel will be done using one of the two concentrations under investigation. In half of the sample of each concentration, the gel will be activated with a LED/laser device for a total of 3 min, as specified by the DMC manufacturer.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participants should have good general and oral health
* Participants should have six caries-free maxillary anterior teeth without restorations on the labial surfaces
* Participants should be willing to sign a consent form
* Participants should have central incisors darker than shade C2.
Exclusion Criteria
* Participants that had labial anterior restorations, were pregnant or lactating.
* Participants with severe internal tooth discoloration (such as tetracycline stains, fluorosis, pulpless teeth).
* Participants with bruxism habits or any gross pathology in the mouth
18 Years
30 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidade Estadual de Ponta Grossa
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Alessandra Reis
PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alessandra Reis, DDS, MS
Role: PRINCIPAL_INVESTIGATOR
Universidade Estadual de Ponta Grossa
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
School of Dentistry - Universidade Estadual de Ponta Grossa
Ponta Grossa, Paraná, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ARAL001
Identifier Type: -
Identifier Source: org_study_id